Approved
consistent with CDC response to OMB questions and comments.
Inventory as of this Action
Requested
Previously Approved
07/31/2009
24 Months From Approved
2,390
0
0
1,033
0
0
0
0
0
The Centers for Disease Control and
Prevention (CDC) requests approval by the Office of Management and
Budget (OMB) for a one-time collection of information to assess
primary care physicians' attitudes and practices regarding prostate
cancer screening. The survey will be conducted with a nationally
representative sample of primary care physicians. The data
collection is central to the prevention research agenda of the
Division of Cancer Prevention and Control, CDC. Prostate cancer is
the most commonly diagnosed cancer among men in the United States.
In 2006, it is estimated that approximately 234,460 new cases of
prostate cancer will be diagnosed and 27,350 men will die from the
disease (American Cancer Society, 2006). Since prostate cancer in
men is different from other cancers, major medical organizations
are divided on whether men should be routinely screened for this
disease. To date, no comprehensive national survey has been
conducted to assess primary care physician attitudes and practices
related to prostate cancer screening. The survey will be
administered by mail to a random sample of about 3,000 primary care
physicians; thereby (a) providing national estimates of physician
use of PSA screening, (b) examining beliefs regarding the efficacy
of prostate cancer screening and treatment, and (c) assessing the
situations in which physicians recommend screening and using PSA
and/or DRE as well as which guidelines they follow. CDC will use
the results from this survey to examine the demographic,
behavioral, attitudinal, and situational characteristics that
influence physician's screening behaviors. Primary care physicians
include the specialties of family medicine, general practice, and
general internal medicine. Primary care physicians in these
specialties are likely to have a patient population of males age 40
and older. The sample will be stratified by race in order to allow
race comparisons on attitudes and practices. Weighting the survey
particpants by probability of selection will allow us to describe
and generalize findings to the primary care population. Information
gathered from a national survey will allow CDC, other researchers,
and clinicians to: (1) examine how PSA testing, DRE, and prostate
cancer screening follow-up are conducted in community practice
across the Untied States, and (2) provide a valuable knowledge base
to guide the development and implementation of interventions to
improve primary care physician adherence to established prostate
cancer screening guidelines in the United States. Conducting a
nationally representative survey will allow the CDC to develop
evidence-based materials likely to be more effective in supporting
optimal clinical practice and helping providers to counsel patients
regarding PSA testing. Without this study, CDC would have limited
knowledge of the variables that influence primary care physician
practices regarding prostate cancer. It would be difficult for CDC
to advise and inform states, other organizations that develop
clinical training materials, physician decision support tools (such
as informed decision making), and materials physicians use to
manage, counsel and educate patients regarding prostate cancer and
PSA screeening.
US Code:
42
USC 301 Name of Law: Public Health Service Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Screening for Survey of Primary Care Physicians Practices Regarding Prostate Cancer Screening
MD Survey Supporting Statement B and Bibliography.doc
Attachment 2. 60d FRN 2006.pdf
Screening for Survey of Primary Care Physicians Practices Regarding Prostate Cancer Screening